[Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children].

Aim: To study the efficacy and tolerability of cortexin in the treatment of cognitive dysfunction in children.

Material And Methods: The study included 635 patients, aged 3-7 years. Patients were divided into 4 clinical groups: group 1 (269 children with attention deficit hyperactivity disorder (ADHD)), group 2 (215 children with speech delay), group 3 (82 patients with the consequences of a perinatal lesion of the central nervous system), group 4 (69 patients with asthenic/neurotic syndrome).